Centre Henri Becquerel
Clinical trials sponsored by Centre Henri Becquerel, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Caregiver training may ease burden after head and neck cancer surgery Results expected Oct 2026 (estimated)
- New scan could spot hidden heart valve infections Results expected Dec 2026 (estimated)
- New PET scan may tell doctors if chemo wiped out breast cancer without surgery Results expected Sep 2027 (estimated)
- Bone scan boost: could Whole-Body SPECT sharpen radiation targeting for metastatic prostate cancer? Results expected Sep 2027 (estimated)
-
Blood test may replace biopsies for rare lymphoma monitoring
Knowledge-focused OngoingThis study looks at whether analyzing tumor DNA from blood samples (called ctDNA) can be a reliable way to monitor peripheral T-cell lymphoma, a rare blood cancer. Researchers will take blood from 45 patients at diagnosis, during treatment, and at relapse to see if the method wor…
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may spot cancer return weeks earlier after CAR-T
Knowledge-focused OngoingThis study tracks 40 patients with aggressive B-cell lymphoma who have received CAR-T cell therapy. Researchers take a blood sample 7 days after treatment to look for leftover tumor DNA. The goal is to see if they can report results within 3 weeks, giving doctors a head start to …
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could a DNA swab after surgery predict Cancer's return?
Knowledge-focused OngoingThis study looks at whether testing the surgical wound for leftover tumor DNA can help predict if oral cancer will come back. Researchers will check for this DNA in 31 patients after their tumor is removed. The goal is to see if this test gives useful information beyond standard …
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may replace scans for lymphoma monitoring
Knowledge-focused OngoingThis study is testing whether a blood test that looks for tumor DNA (called ctDNA) can predict if lymphoma will come back after first treatment. Researchers will compare this 'liquid biopsy' to standard PET scans in 108 adults with B-cell or Hodgkin lymphoma. The goal is to see i…
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC